Sojan Joseph

The Online Safety Act has been designed to be technology neutral and applies to all services which support user-to-user interactions online, including game services. Where gaming services fall in scope, they will need to take appropriate measures to protect their users against illegal harms and harms to children.

Department for Transport Ministers and officials regularly meet colleagues from the Home Office, the Cabinet Office and FCDO to discuss the impacts of the EU Entry/Exit System on travel between the UK and the Schengen Area, including the impacts on freight. We are intensifying these discussions with our ministerial colleagues across government as we approach the implementation date.

I can confirm that a cut of the field to remove the thistles and ragwort was completed by Sunday 8th September. The cut was started following an ecological walkover visit on Monday 2nd September to ensure that the works could go ahead without impacting nesting birds.

There are no plans to abolish parking charges for National Health Service staff.

All trusts that charge for hospital car parking provide free parking to ‘in-need groups’, which include NHS staff working overnight, frequent outpatient attenders, disabled people and parents of children staying overnight in hospital.

The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. As a result of our intensive work, some issues have been resolved. Many strengths of lisdexamfetamine and all strengths of atomoxetine capsules and guanfacine prolonged-release tablets are now available. We are working to resolve medicine supply issues, where they remain, for some strengths of lisdexamfetamine and methylphenidate. These are anticipated to resolve by August and October 2024, respectively.

We have engaged with all suppliers of methylphenidate prolonged-release tablets to discuss the challenges faced and their actions to address them. We are asking suppliers to secure additional stocks, expedite deliveries where possible, and review plans to further build capacity to support continued growth in demand for the short and long-term.

The Department has worked with specialist clinicians to develop management advice for National Health Service clinicians to consider prescribing available alternative brands of methylphenidate prolonged release tablets. We would expect ADHD service providers and specialists to follow our guidance to offer rapid response to primary care teams seeking urgent advice or opinion for the management of patients including those known to be at a higher risk of adverse impact because of these shortages.

To aid ADHD service providers and prescribers further, we have widely disseminated our communications and continually update a list of currently available and unavailable ADHD products on the Specialist Pharmacy Service website, helping ensure that those involved in the prescribing and dispensing of ADHD medications can make informed decisions with patients, which is available at the following link:

https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/